Novartis HQ is pulling up its roots in the UK and moving to a new biotech campus in London
Novartis is joining the migration of the major players directly into the heart of the world’s biggest biotech R&D hubs.
The Basel-based pharma giant put out word today that they have decided to relocate their headquarters in the UK from their site at Frimley in Surrey to a new campus bordering Imperial College London’s research and innovation campus. That will trigger the relocation of some 600 staffers to 54,000-square-feet at The WestWorks, part of the rebirth of the old BBC Media Village campus in the White City area that is now home to a group of British biotech players.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.